Search results
Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital - ET...
The Economic Times· 3 days agoLondon: Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go...
Nazara Tech likely to acquire remaining 49% stake in Kiddopia for ₹300 crore, sources say - CNBC...
CNBC TV18· 5 days agoGaming company Nazara Technologies plans to buy the remaining 49% stake in its subsidiary and...
Gourmet Gateway Ltd Stock Price: Gourmet Gateway Share Price Today | India Infoline
India Infoline· 21 hours agoIntellivate Capital Ventures Limited was incorporated on November 18, 1982 in the name of K. B. Steel, and was granted Certificate for Commencement of Business on March 22, 1983. The name of ...
Koo's flight cut short: Twitter challenger grounded by merger collapse
Business Standard India· 3 days agoBeleaguered microblogging platform Koo, once seen as a home-grown rival to social media giant X...
M&A deal value slows down by 9% to $38 billion in first half of 2024
Business Standard India· 5 days agoM&A deal value down: Deals to pick up in the second half, say bankers
Indian Startups Raised Nearly $7 Billion In First Half Of 2024
Free Press Journal· 3 days agoThe USD 7 billion funding included 182 growth or late-stage deals worth USD 5.4 billion and 404...
Delisting process: Sebi’s fixed price model may face acceptance hurdle
Financial Express· 4 days agoIn an effort to simplify the delisting process from the securities market, the Securities and...
Indian pharma industry eyes 9% annual growth on strong domestic and export markets, says report
Business Today· 6 days agoThe agency anticipates an approximate 9% growth rate for the industry during FY25-FY27, potentially...
FMCG deals on the fast track; M&As in sector hit $938 million in H1, highest in 4 years
Financial Express· 1 day agoThe domestic FMCG sector has experienced a rise in mergers and acquisitions, reaching $938 million...
Tracon mulls strategic options after sarcoma drug fails Phase II trial
Pharmaceutical Technology· 4 days agoTracon has discontinued all its clinical development activities related to envafolimab and plans to...